fluorodeoxyglucose f18 has been researched along with Gangliosidosis, GM1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Essa, MA; Bakheet, SM; Nounou, RM; Ozand, PT; Patay, ZJ | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Gangliosidosis, GM1
Article | Year |
---|---|
Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis.
Topics: Brain; Fluorodeoxyglucose F18; Gangliosidosis, GM1; Humans; Infant; Lymphocytes; Magnetic Resonance Imaging; Male; Tomography, Emission-Computed | 1999 |